Morning Breakouts

Latest KFF Health News Stories

Races Tighten Over Health Overhaul Issues As Clock Ticks Down To Midterm Elections

Morning Briefing

Races around the nation are being scrutinized for a glimpse of an edge when it comes to health reform and what the races mean for the health overhaul in America after next week’s midterm elections.

Health Reform Implementation: Insurance Options, States And Exchanges, ACOs

Morning Briefing

Provisions of the health overhaul that have already been implemented will change next year’s insurance offerings – and should give employees a good reason to pay attention to their options before renewing plans.

HHS Approves Hundreds More Local Gov’ts, Businesses, Unions For Early Retiree Health Program

Morning Briefing

More than 3,000 organizations nationwide are now participating in the Affordable Care Act’s Early Retiree Reinsurance Program, which partially reimburses employees for the cost of health benefits provided to early retirees.

Enrollees In High-Deductible Plans May Be Forgoing Care Because Of High Costs

Morning Briefing

People enrolled in high-deductible plans may forgo care because of excessive out-of-pocket costs, according to a new report from the UCLA Center for Health Policy Research.

Research Roundup: Primary Care Doc Pay And Satisfaction; Fixes To Medicare Reimbursements; Free Vaccines?

Morning Briefing

This week’s research roundup includes studies from Health Affairs, the Archives of Internal Medicine, the American Journal of Public Health, UCLA Center for Health Policy Research, the Kaiser Family Foundation, the Urban Institute and the National Minority Quality Forum.

First Edition: October 29, 2010

Morning Briefing

Today’s early morning highlights from the major news organizations, including reports about the effort to repeal the health law and Republican and Democrat strategies related to health overhaul policies in the next Congress.

PHARMABIZ.com Examines India’s Push For Clearer Definition Of Counterfeit, Substandard Medicines

Morning Briefing

“India has taken the lead to get together a number of generic drug-producing nations to call for better definitions to ensure quality, strengthening of regulatory authorities in the respective countries, and bringing focus of the world to public health instead of intellectual property,” PHARMABIZ.com writes in an article that examines the recent meeting of leaders from Brazil, India and South Africa on issues regarding counterfeit medicines. “The initiative came as an inter-governmental working group, appointed by the World Health Assembly last year, is looking at the WHO’s role to ensure the availability of quality, safe and efficacious and affordable medicine,” according to the new service.